Literature DB >> 18408577

Recovery of heart function in children with acute severe heart failure.

John J O'Sullivan1, Susan L Roche, David S Crossland, Milind P Chaudhari, Richard C Kirk, Hasan Asif.   

Abstract

BACKGROUND: The prognosis of acute heart failure is such that many children are considered for transplantation. Recovery of severe heart failure in a proportion of patients diagnosed with either dilated cardiomyopathy or myocarditis is well recognized, and this complicates the assessment for transplantation. There is little data on the time scale of recovery of heart function in children.
OBJECTIVES: To describe the time course over which echocardiographic improvement of systolic function occurred in a cohort of children who presented in acute heart failure, without structural or metabolic abnormality.
METHODS: Children with a first presentation of acute severe heart failure between 1990 and 2005. Time from presentation to the echocardiogram before left ventricular fractional shortening (FS) improved to 20% and 30% (complete recovery) was recorded.
RESULTS: Twenty-seven children (11 male) were identified, and all had an initial FS <15%. Twenty-one patients required intravenous inotropes and three patients required extracorporeal membrane oxygenation. Seven patients had been on the active transplant list for a mean duration of 155 days. Four patients had probable viral myocarditis. Mean age at presentation was 15.7 (range, 0.1-72) months. Mean time to an FS of 20% was 3.6 (0.2-18) months and to 30% was 8.9 (0.7-24) months. Complete recovery occurred within 6, 9, 12, 18, and 24 months of presentation in 44%, 55%, 66%, and 96%, respectively. There was no correlation between age of presentation and length of time to recovery.
CONCLUSIONS: Complete recovery of left ventricular systolic function is often delayed to more than 1 year from presentation. This may have major implications for timing of transplantation in an era where prolonged mechanical cardiac support is feasible even in infants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18408577     DOI: 10.1097/TP.0b013e318168fe3c

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry.

Authors:  Melanie D Everitt; Lynn A Sleeper; Minmin Lu; Charles E Canter; Elfriede Pahl; James D Wilkinson; Linda J Addonizio; Jeffrey A Towbin; Joseph Rossano; Rakesh K Singh; Jacqueline Lamour; Steven A Webber; Steven D Colan; Renee Margossian; Paul F Kantor; John L Jefferies; Steven E Lipshultz
Journal:  J Am Coll Cardiol       Date:  2014-02-19       Impact factor: 24.094

2.  Lethal influenza B myocarditis in a child and review of the literature for pediatric age groups.

Authors:  H Frank; C Wittekind; U G Liebert; M Siekmeyer; W Siekmeyer; V Schuster; W Kiess
Journal:  Infection       Date:  2010-04-01       Impact factor: 3.553

Review 3.  Pediatric heart failure: current state and future possibilities.

Authors:  Joseph W Rossano; Gi Young Jang
Journal:  Korean Circ J       Date:  2015-01-26       Impact factor: 3.243

4.  Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy.

Authors:  Heiner Latus; Kerstin Gummel; Karin Klingel; Axel Moysich; Markus Khalil; Nona Mazhari; Juergen Bauer; Reinhard Kandolf; Dietmar Schranz; Christian Apitz
Journal:  J Cardiovasc Magn Reson       Date:  2015-05-15       Impact factor: 5.364

5.  Circulating Long Non-coding RNA ENST00000507296 Is a Prognostic Indicator in Patients with Dilated Cardiomyopathy.

Authors:  Xudong Zhang; Xiang Nie; Shuai Yuan; Huaping Li; Jiahui Fan; Chenze Li; Yang Sun; Yanru Zhao; Huiying Hou; Dao Wen Wang; Chen Chen
Journal:  Mol Ther Nucleic Acids       Date:  2019-02-16       Impact factor: 8.886

Review 6.  Epidemiology and cost of heart failure in children.

Authors:  Deipanjan Nandi; Joseph W Rossano
Journal:  Cardiol Young       Date:  2015-12       Impact factor: 1.093

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.